基于网络药理学探讨温胆汤对痰浊中阻型后循环缺血性眩晕的作用机制
The Mechanism of Warm Bile Soup on Circulating Ischemic Vertigo Was Investigated Based on Network Pharmacology
DOI: 10.12677/tcm.2025.141068, PDF,   
作者: 温旖蓝*, 李 蒙, 贺天琪, 闫 雨：广西中医药大学研究生院，广西 南宁；方 兴：广西中医药大学附属瑞康医院，广西 南宁
关键词: 温胆汤；网络药理学；Warm Bile Soup； Network Pharmacology
摘要: 本研究旨在利用网络药理学方法预测温胆汤在治疗痰浊中阻型PCIV的潜在作用机制。利用多个数据库、分析平台及文献检索，收集出温胆汤中各中药成分靶点与疾病靶点，取其共同交集靶点，并进行基因本体(GO)和京都基因与基因组百科全书(KEGG)的富集分析，同时使用相关软件分别构建出成分–疾病–通路靶点网络和蛋白质–蛋白质相互作用网络图。经分析筛选后，在温胆汤中发现49种活性化合物，其中与PCIV相关的共139个靶点。药物主要成分包括柚皮苷、槲皮素、木犀草素、黄芩苷，关键核心靶点包括IL6、TNF、STAT3等。KEGG信号通路包括癌症的途径、脂质和动脉粥样硬化、化学致癌作用–受体激活、IL-17信号等。结论：温胆汤对PCIV的治疗作用可能是通过柚皮苷、黄芩苷等成分及调节IL6、TNF等靶点从而参与抗炎、促进脂质代谢等多条途径。
Abstract: This study aimed to predict the potential mechanism of warm bile soup in the treatment of sputum resistant PCIV. Using multiple databases, analysis platform and literature retrieval, collect the Chinese medicine composition targets and disease targets, take the common intersection targets, and gene ontology (GO) and Kyoto gene and genome encyclopedia (KEGG) enrichment analysis, at the same time using the related software to build components-disease-pathway target network and protein-protein interaction network diagram. After analytical screening, 49 active compounds were found in bile soup, including a total of 139 targets associated with PCIV. The main components of the drugs include naringin, quercetin, luteolin, and baicalin, and the key core targets include IL 6, TNF, and STAT 3. KEGG signaling pathways including cancer pathway, lipids and atherosclerosis, chemical carcinogenesis-receptor activation, IL-17 signaling, etc. Conclusion: The therapeutic effect of bile soup on PCIV may be through naringin, baicalin and other components and targets such as IL 6 and TNF to participate in anti-inflammation and promote lipid metabolism.
文章引用：温旖蓝, 方兴, 李蒙, 贺天琪, 闫雨. 基于网络药理学探讨温胆汤对痰浊中阻型后循环缺血性眩晕的作用机制[J]. 中医学, 2025, 14(1): 462-469. https://doi.org/10.12677/tcm.2025.141068

参考文献

[1] 高喜梅, 贾萌, 池玉梅, 等．温胆汤治疗神经系统疾病的物质基础及作用机制研究进展[J]. 中国实验方剂学杂志, 2019, 25(10): 188-196．
[2] Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., et al. (2014) TCMSP: A Database of Systems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[3] Kim, S. (2016) Getting the Most Out of Pubchem for Virtual Screening. Expert Opinion on Drug Discovery, 11, 843-855. [Google Scholar] [CrossRef] [PubMed]
[4] Wu, Y., Liu, X. and Li, G. (2022) Integrated Bioinformatics and Network Pharmacology to Identify the Therapeutic Target and Molecular Mechanisms of Huangqin Decoction on Ulcerative Colitis. Scientific Reports, 12, Article No. 159. [Google Scholar] [CrossRef] [PubMed]
[5] The UniProt Consortium (2021) UniProt: The Universal Protein Knowledge Base in 2021. Nucleic Acids Research, 49, D480-D489.
[6] Zhang, L., Han, L., Wang, X., Wei, Y., Zheng, J., Zhao, L., et al. (2021) Exploring the Mechanisms Underlying the Therapeutic Effect of salvia Miltiorrhiza in Diabetic Nephropathy Using Network Pharmacology and Molecular Docking. Bioscience Reports, 41, BSR20203520. [Google Scholar] [CrossRef] [PubMed]
[7] Szklarczyk, D., Gable, A.L., Nastou, K.C., Lyon, D., Kirsch, R., Pyysalo, S., et al. (2020) The STRING Database in 2021: Customizable Protein-Protein Networks, and Functional Characterization of User-Uploaded Gene/Measurement Sets. Nucleic Acids Research, 49, D605-D612. [Google Scholar] [CrossRef] [PubMed]
[8] 纪震, 矫翠翠, 王丹丹, 等. 苦碟子注射液联合脑蛋白水解物对后循环缺血性眩晕患者的临床疗效[J]. 中成药, 2022, 44(8): 2514-2518.
[9] 何菊, 张怀亮. 后循环缺血性眩晕的中西医研究进展[J]. 中国中医基础医学杂志, 2018, 24(6): 871-874.
[10] 王靖, 可海霞, 王敏. 三七通舒胶囊联合脑蛋白水解物对后循环缺血性眩晕患者的临床疗效[J]. 中成药, 2021, 43(4): 1108-1111.
[11] 刘爱华, 韩振翔. 黄芪赤风汤合补中益气汤对气虚血瘀型后循环缺血性眩晕患者的临床疗效[J]. 中成药, 2019, 41(3): 713-716.
[12] 王鑫淼, 于骄洋, 程美佳, 等. 基于痰瘀互结理论探讨血脂异常对轻度认知障碍的影响[J]. 辽宁中医药大学学报, 2022, 24(4): 121-125.
[13] 孙琛琛, 杨惠民, 郭杨志, 等. 中医药对血脂异常的认识及进展[J]. 中医药信息, 2018, 35(1): 123-128.
[14] 李庆耀, 梁生林. 陈皮的药用研究进展[J]. 中成药, 2008(2): 246-248.
[15] 皮达(Pei-kun). 药典所载四种陈皮的比较研究[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2020.
[16] Cao, H., Jia, Q., Yan, L., Chen, C., Xing, S. and Shen, D. (2019) Quercetin Suppresses the Progression of Atherosclerosis by Regulating MST1-Mediated Autophagy in ox-LDL-Induced RAW264.7 Macrophage Foam Cells. International Journal of Molecular Sciences, 20, Article 6093. [Google Scholar] [CrossRef] [PubMed]
[17] 林烨, 柳丽, 孙静, 等. 木犀草素防治糖尿病的作用机制研究进展[J/OL]. 中药药理与临床: 1-12. 2024-05-22.[CrossRef] 
[18] 孙霁寒, 王兆丹, 孙桂菊, 等. 木犀草素对高血脂症SD大鼠肝脏脂肪变性及抗氧化水平的影响[J]. 食品工业科技, 2019, 40(11): 308-312+317.
[19] 张前, 杨浩, 陈博, 等. 黄芩苷防治中枢神经系统疾病的研究进展[J]. 中国药师, 2017, 20(2): 327-331.
[20] 陈忻, 董晓丹, 张楠, 等. 黄芩苷对局灶性脑缺血大鼠的保护作用[J]. 广州中医药大学学报, 2006, 23(6): 506-508.
[21] Kang, S., Tanaka, T., Narazaki, M. and Kishimoto, T. (2019) Targeting Interleukin-6 Signaling in Clinic. Immunity, 50, 1007-1023. [Google Scholar] [CrossRef] [PubMed]
[22] Cohen, T., Nahari, D., Cerem, L.W., Neufeld, G. and Levi, B. (1996) Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor. Journal of Biological Chemistry, 271, 736-741. [Google Scholar] [CrossRef] [PubMed]
[23] Stenlöf, K., Wernstedt, I., Fjällman, T., Wallenius, V., Wallenius, K. and Jansson, J. (2003) Interleukin-6 Levels in the Central Nervous System Are Negatively Correlated with Fat Mass in Overweight/Obese Subjects. The Journal of Clinical Endocrinology & Metabolism, 88, 4379-4383. [Google Scholar] [CrossRef] [PubMed]
[24] Timper, K., Denson, J.L., Steculorum, S.M., Heilinger, C., Engström-Ruud, L., Wunderlich, C.M., et al. (2017) IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 Trans-Signaling. Cell Reports, 19, 267-280. [Google Scholar] [CrossRef] [PubMed]
[25] Kerkis, I., Silva, Á.P.d. and Araldi, R.P. (2024) The Impact of Interleukin-6 (IL-6) and Mesenchymal Stem Cell-Derived IL-6 on Neurological Conditions. Frontiers in Immunology, 15, Article 1400533. [Google Scholar] [CrossRef] [PubMed]
[26] Matsumoto, J., Dohgu, S., Takata, F., Machida, T., Bölükbaşi Hatip, F.F., Hatip-Al-Khatib, I., et al. (2018) TNF-α-Sensitive Brain Pericytes Activate Microglia by Releasing IL-6 through Cooperation between IκB-NFκB and JAK-STAT3 Pathways. Brain Research, 1692, 34-44. [Google Scholar] [CrossRef] [PubMed]
[27] Persson, J., Nilsson, J. and Lindholm, M.W. (2008) Interleukin-1β and Tumour Necrosis Factor-α Impede Neutral Lipid Turnover in Macrophage-Derived Foam Cells. BMC Immunology, 9, Article No. 70.
[28] 王丹,王肖龙.基于网络药理学、分子对接与实验验证揭示薯蓣皂苷元治疗动脉粥样硬化的作用机制[J].中草药, 2022, 53(24):7783-7794.
[29] Chen, Q., Lv, J., Yang, W., Xu, B., Wang, Z., Yu, Z., et al. (2019) Targeted Inhibition of STAT3 as a Potential Treatment Strategy for Atherosclerosis. Theranostics, 9, 6424-6442. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, R., Zhang, Y., Xu, L., Lin, Y., Yang, X., Bai, L., et al. (2016) Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-Induced Cell Responses during Atherosclerosis in Apolipoprotein E-Deficient Mice. Scientific Reports, 6, Article No. 36790. [Google Scholar] [CrossRef] [PubMed]
[31] Yang, L., Song, Z., Pan, Y., Zhao, T., Shi, Y., Xing, J., et al. (2021) PM2.5 Promoted Lipid Accumulation in Macrophage via Inhibiting JAK2/STAT3 Signaling Pathways and Aggravating the Inflammatory Reaction. Ecotoxicology and Environmental Safety, 226, Article 112872. [Google Scholar] [CrossRef] [PubMed]
[32] Song, H., Cui, Y., Zhang, L., Cao, G., Li, L., Li, G., et al. (2020) Ruxolitinib Attenuates Intimal Hyperplasia via Inhibiting JAK2/STAT3 Signaling Pathway Activation Induced by PDGF-BB in Vascular Smooth Muscle Cells. Microvascular Research, 132, Article 104060. [Google Scholar] [CrossRef] [PubMed]
[33] Li, S., Geng, Q., Chen, H., Zhang, J., Cao, C., Zhang, F., et al. (2017) The Potential Inhibitory Effects of Mir‑19b on Vulnerable Plaque Formation via the Suppression of STAT3 Transcriptional Activity. International Journal of Molecular Medicine, 41, 859-867. [Google Scholar] [CrossRef] [PubMed]